Oracle
ORCL
Netflix
NFLX
Meta Platforms
META
4
Apple
AAPL
5
Tesla
TSLA
US Stock MarketDetailed Quotes
LEXX Lexaria Bioscience
- 1.220
- -0.130-9.63%
Close Apr 28 16:00 ET
21.42MMarket Cap-2.00P/E (TTM)
1.280High1.220Low129.95KVolume1.260Open1.350Pre Close160.86KTurnover0.83%Turnover RatioLossP/E (Static)17.56MShares4.44052wk High3.00P/B19.15MFloat Cap1.15052wk Low--Dividend TTM15.70MShs Float12.500Historical High--Div YieldTTM4.44%Amplitude0.649Historical Low1.237Avg Price1Lot Size
Lexaria Bioscience Key Stats
Quarterly+Annual
YOY
| (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.00%174K | 21.58%183.92K | 105.24%464.28K | 173.25%84K | 8.10%84K | 624.09%145K | 54.78%151.28K | -11.43%226.21K | -72.34%30.74K | -22.07%77.71K |
| Operating revenue | 20.00%174K | 22.31%183.92K | 142.65%463.38K | 100.64%84K | 8.10%84K | 624.09%145K | 62.51%150.38K | 13.67%190.97K | 4.04%41.87K | -22.07%77.71K |
| Cost of revenue | 0 | -43.59%2.72K | -84.69%4.82K | 0 | 0 | 0 | -69.47%4.82K | -56.15%31.5K | 0 | -31.60%12.75K |
| Gross profit | 20.00%174K | 23.73%181.2K | 135.97%459.46K | 173.25%84K | 29.31%84K | 749.59%145K | 78.74%146.46K | 6.08%194.71K | -56.02%30.74K | -19.88%64.96K |
| Operating expense | 259.78%2.93M | 123.39%2.87M | -7.67%6.21M | 99.77%2.29M | -25.91%1.83M | -39.36%813.01K | -27.67%1.29M | -1.09%6.73M | 39.88%1.14M | -1.34%2.47M |
| Selling and administrative expenses | 118.45%1.24M | 29.19%918.69K | 25.80%3.85M | 104.80%1.32M | 51.95%1.25M | -11.99%567.23K | -24.98%711.11K | -38.26%3.06M | 39.41%644.45K | -52.77%825.18K |
| -General and administrative expense | 118.45%1.24M | 29.19%918.69K | 25.80%3.85M | 104.80%1.32M | 51.95%1.25M | -11.99%567.23K | -24.98%711.11K | -38.26%3.06M | 39.41%644.45K | -52.77%825.18K |
| Research and development costs | 585.95%1.69M | 239.99%1.95M | -35.62%2.36M | 93.28%967.21K | -65.07%573.09K | -64.70%245.78K | -30.74%574.49K | 98.99%3.67M | 40.49%500.41K | 118.14%1.64M |
| Operating profit | -311.83%-2.75M | -136.20%-2.69M | 11.95%-5.75M | -97.74%-2.2M | 27.40%-1.74M | 49.53%-668.01K | 32.81%-1.14M | 1.28%-6.53M | -48.84%-1.11M | 0.72%-2.4M |
| Net non-operating interest income expense | 0 | -99.85%11 | -66.87%14.31K | -22.44%6.99K | 0 | -100.01%-1 | 95.64%7.32K | 43.19K | 9.02K | 15.44K |
| Non-operating interest income | --0 | -99.85%11 | -66.87%14.31K | -22.44%6.99K | --0 | ---- | 95.64%7.32K | --43.19K | --9.02K | --15.44K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | --1 | ---- | ---- | ---- | ---- |
| Other net income (expense) | 122.88%34.04K | 70.06%-15.93K | 68.50%-69.84K | 106.60%9.5K | -2,330.23%-41.39K | 862.51%15.27K | 31.45%-53.22K | 71.01%-221.69K | -143.92K | 1.86K |
| Gain on sale of security | 122.88%34.04K | 70.06%-15.93K | 68.50%-69.84K | 106.60%9.5K | -2,330.23%-41.39K | 862.51%15.27K | 31.45%-53.22K | 71.01%-221.69K | ---143.92K | --1.86K |
| Income before tax | -316.25%-2.72M | -128.40%-2.71M | 13.47%-5.81M | -75.06%-2.19M | 25.14%-1.78M | 50.20%-652.73K | 33.02%-1.19M | 9.09%-6.71M | 17.46%-1.25M | 1.44%-2.38M |
| Income tax | ||||||||||
| Net income | -316.25%-2.72M | -128.40%-2.71M | 13.47%-5.81M | -75.06%-2.19M | 25.14%-1.78M | 50.20%-652.73K | 33.02%-1.19M | 9.09%-6.71M | 17.46%-1.25M | 1.44%-2.38M |
| Net income continuous Operations | -316.25%-2.72M | -128.40%-2.71M | 13.47%-5.81M | -75.06%-2.19M | 25.14%-1.78M | 50.20%-652.73K | 33.02%-1.19M | 9.09%-6.71M | 17.46%-1.25M | 1.44%-2.38M |
| Minority interest income | -17.72%-3.76K | 48.75%-2.93K | 72.06%-13.31K | 81.63%-1.78K | 78.29%-2.62K | 74.46%-3.19K | 57.23%-5.72K | 58.34%-47.63K | 78.78%-9.7K | 65.94%-12.06K |
| Net income attributable to the parent company | -317.71%-2.71M | -129.26%-2.7M | 13.05%-5.8M | -76.29%-2.18M | 24.87%-1.78M | 49.96%-649.54K | 32.84%-1.18M | 8.31%-6.66M | 15.55%-1.24M | 0.48%-2.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -317.71%-2.71M | -129.26%-2.7M | 13.05%-5.8M | -76.29%-2.18M | 24.87%-1.78M | 49.96%-649.54K | 32.84%-1.18M | 8.31%-6.66M | 15.55%-1.24M | 0.48%-2.37M |
| Basic earnings per share | -150.00%-0.15 | -23.08%-0.16 | 53.47%-0.47 | -25.00%-0.15 | 64.86%-0.13 | 72.73%-0.06 | 56.67%-0.13 | 18.55%-1.01 | 50.00%-0.12 | 9.76%-0.37 |
| Diluted earnings per share | -150.00%-0.15 | -23.08%-0.16 | 53.47%-0.47 | -25.00%-0.15 | 64.86%-0.13 | 72.73%-0.06 | 56.67%-0.13 | 18.55%-1.01 | 50.00%-0.12 | 9.76%-0.37 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025